Update on depression and age-related macular degeneration.
Update on depression and age-related macular degeneration.
复制标题
DOI：
10.1097/icu.0b013e32835f8e55
复制
发表时间：
2013-05
影响因子：
3.7
通讯作者：
Rovner BW
中科院分区：
文献类型：
--
作者：
Casten RJ;Rovner BW
本文综述了老年性黄斑变性抑郁症的最新研究进展。自2004年对抑郁症和AMD的回顾以来，AMD的治疗已经发生了革命性的变化。新的数据描述抑郁症的患病率在AMD，以及新的干预措施，为管理抑郁症在AMD，进行了讨论。抑郁症在AMD中仍然普遍存在，并且可以获得关于视力受损导致抑郁症的途径的新信息。治疗视力受损患者抑郁症的策略已经发展。AMD仍然是抑郁症的主要危险因素，由于视力丧失而活动受限的人风险最大。对视力受损的老年人进行抑郁症管理的综合方法可能是最好的行动方案。
This review updates the literature on depression in age-related macular degeneration. Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed. Depression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved. AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.